Scientists discover gene switch important in cancer
Scientists at Karolinska Institutet in Sweden and the University of Helsinki in Finland have shown that the "switches" that regulate the expression of genes play a major role in the development of cancer. In a study, published ...
Cancer
Nov 01, 2012 |
5 / 5 (1) |
0
|
Progress in ultrasound-guided surgery may improve breast cancer treatment
When surgeons operate to remove a tumor, determining exactly where to cut can be tricky. Ideally, the entire tumor should be removed while leaving a continuous layer of healthy tissue, but current techniques for locating ...
Surgery
Oct 26, 2012 |
not rated yet |
0
New options for ease and accuracy in extraction of rare cells or separating blood
(Medical Xpress)—Using something called "inertial microfluidics," University of Cincinnati researchers are able to continuously and selectively collect rare cells, such as circulating tumor cells, based ...
Cancer
Oct 26, 2012 |
not rated yet |
0
|
New research uncovers promising new biomarker for aggressiveness of prostate cancer, implications for treatment
Research out of Roswell Park Cancer Institute (RPCI) supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors. A team of investigators from three institutions, led by Shahriar Koochekpour, ...
Cancer
Oct 24, 2012 |
not rated yet |
0
Noninvasive assay monitored treatment response in patients with metastatic prostate cancer
Deciding the ideal treatment for patients with metastatic prostate cancer that stops responding to initial therapy could be guided by certain analyses of cancer cells isolated from the patients' blood, according to data published ...
Cancer
Oct 23, 2012 |
not rated yet |
0
|
Stat5 predicts outcomes for prostate cancer patients after radical prostatectomy
Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of ...
Cancer
Oct 16, 2012 |
not rated yet |
1
Researchers reveal how Trop2 protein drives tumor growth in prostate, other epithelial cancers
(Medical Xpress)—Researchers led by Tanya Stoyanova and Dr. Owen Witte of UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have determined how a protein known as Trop2 drives the growth ...
Cancer
Oct 16, 2012 |
not rated yet |
0
|
Prostate cancer: Curcumin curbs metastases
Powdered turmeric has been used for centuries to treat osteoarthritis and other illnesses. Its active ingredient, curcumin, inhibits inflammatory reactions. A new study led by a research team at Ludwig-Maximilians-Universität ...
Cancer
Oct 12, 2012 |
5 / 5 (2) |
0
|
Study discovers gene signature that predicts prostate cancer survival
Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October ...
Cancer
Oct 10, 2012 |
not rated yet |
0
Gene mutation can allow proteins to gather, spark tumor growth
Prostate cancer is generally treated as if it's a single disease. But researchers have discovered a new type of the cancer that appears to affect 15 percent of patients, a finding that paves the way for better diagnosis and ...
Cancer
Sep 07, 2012 |
5 / 5 (1) |
0
Taking breaks from prostate cancer hormone therapy seems safe: study
(HealthDay)—Stop-and-start hormone-deprivation therapy for localized prostate cancer doesn't shorten overall survival compared to continuous treatments, and yields fewer side effects such as impotence and ...
Cancer
Sep 05, 2012 |
not rated yet |
0
|
Team finds biological indicator of aggressive, recurrent forms of prostate cancer
(Medical Xpress)—In a study to decipher clues about how prostate cancer cells grow and become more aggressive, Johns Hopkins urologists have found that reduction of a specific protein is correlated with the aggressiveness ...
Cancer
Aug 27, 2012 |
5 / 5 (1) |
0
|
LPA1 inhibition induces metastatic dormancy in mouse models of breast cancer
A lysophosphatidic acid receptor 1 (LPAR1) inhibitor, known as Debio-0719, suppresses the development of metastases in mice by inducing cancer cell dormancy, according to a study published August 21 in the Journal of the Na ...
Cancer
Aug 21, 2012 |
not rated yet |
0
You could be sick ... but probably not
Do you automatically assume that a headache is a brain tumor? Do you worry that a minor cut could lead to flesh-eating bacteria ravaging a limb and requiring massive surgical intervention?
Health
Aug 14, 2012 |
5 / 5 (2) |
0
Plant-based compound slows breast cancer in a mouse model
The natural plant compound phenethyl isothiocyanate (PEITC) hinders the development of mammary tumors in a mouse model with similarities to human breast cancer progression, according to a study published August 2 in the Journal of ...
Cancer
Aug 02, 2012 |
not rated yet |
0
